Biostar Pharmaceuticals

Biostar Pharmaceuticals EBIT Margin

The EBIT Margin (Operating Margin) of Biostar Pharmaceuticals (BSPM) as of Nov 2, 2026 is -149.50 %. In the previous year, EBIT Margin (Operating Margin) was -87.57 % — a change of 70.71% (lower).

EBIT Margin

-149.50 %

YoY

70.71%

Last updated:

EBIT Margin (Operating Margin) of Biostar Pharmaceuticals is 2016 -149.50 % . EBIT Margin (Operating Margin) of Biostar Pharmaceuticals was 2015 -87.57 % . It decreases by 70.71% lower compared to the previous year.

Biostar Pharmaceuticals's operating (EBIT) margin stands at -149.5%, down from -40.9% several years earlier.

The Biostar Pharmaceuticals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2009
0.28 USD
Jan 1, 2010
0.29 USD
Jan 1, 2011
0.20 USD
Jan 1, 2012
-0.41 USD
Jan 1, 2013
0.01 USD
Jan 1, 2014
-2.14 USD
Jan 1, 2015
-87.57 USD
Jan 1, 2016
-149.50 USD
The Biostar Pharmaceuticals EBIT Margin history
YEAREBIT MarginYoY
-149.50 %+70.71%
-87.57 %+3,996.23%
-2.14 %-22,280.59%
0.01 %-102.35%
-0.41 %-307.28%
0.20 %-32.92%
0.29 %+3.92%
0.28 %+23.73%
0.23 %-24.96%
0.31 %-1.70%
0.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Biostar Pharmaceuticals Stock analysis

What does Biostar Pharmaceuticals do? Biostar Pharmaceuticals Inc. is a leading Chinese biotechnology company that has been operating in the healthcare industry since 1992. The company focuses on the development and marketing of natural medicine and pharmaceutical products. Biostar Pharmaceuticals Inc. is headquartered in Xianyang, China and operates multiple manufacturing facilities and research institutions near Xianyang. Biostar Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biostar Pharmaceuticals stock

EBIT Margin (Operating Margin) of Biostar Pharmaceuticals is -149.50 % in 2016.

EBIT Margin (Operating Margin) of Biostar Pharmaceuticals changed from -87.57 % to -149.50 %, representing a 70.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Biostar Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Biostar Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Biostar Pharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Biostar Pharmaceuticals